Alivus Life Sciences Ltd.

The sales is pegged at Rs. 5092.99 millions for the September 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 5617.61 millions during the year-ago period.A slender decline of -7.22% was recorded to Rs. 1068.78  millions from Rs. 1152.01 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 1536.59 millions from 1694.26 millions in the corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202209	202109	% Var	202209	202109	% Var	202203	202103	% Var
Sales	5092.99	5617.61	-9.34	9991.69	10866.58	-8.05	21232.14	18851.65	12.63
Other Income	100.20	20.89	379.66	195.13	60.75	221.20	147.04	8.11	1713.07
PBIDT	1536.59	1694.26	-9.31	3099.20	3338.60	-7.17	6307.64	5918.85	6.57
Interest	1.33	72.26	-98.16	2.68	277.76	-99.04	279.62	875.47	-68.06
PBDT	1535.26	1622.00	-5.35	3096.52	3060.84	1.17	6028.02	5043.38	19.52
Depreciation	99.35	96.65	2.79	198.14	185.84	6.62	378.77	333.94	13.42
PBT	1435.91	1525.35	-5.86	2898.38	2875.00	0.81	5649.25	4709.44	19.96
TAX	367.13	373.34	-1.66	742.27	713.86	3.98	1462.01	1193.63	22.48
Deferred Tax	28.20	7.91	256.51	41.05	26.00	57.88	85.74	66.17	29.58
PAT	1068.78	1152.01	-7.22	2156.11	2161.14	-0.23	4187.24	3515.81	19.10
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	19.60	1150.26
PBIDTM(%)	30.17	30.16	0.04	31.02	30.72	0.96	29.71	31.40	-5.38